Migraine prophylaxis with topiramate

被引：0
作者：
Gendolla, Astrid [1 ]
Diener, Hans Christoph [1 ]
机构：
[1] Univ Klin Neurol, Westdeutsch Kopfschmerzzentrum, D-45122 Essen, Germany
来源：
PSYCHOPHARMAKOTHERAPIE | 2006年 / 13卷 / 05期
关键词：
migraine; prophylaxis; topiramate;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Topiramate is approved in Germany for the prophylaxis of migraine. Patients with frequent migraine attacks do need prophylactic treatment. Migraine prophylaxis with topiramate has been shown to be effective in three placebo-controlled, randomized trials for preventive migraine therapy. Effective doses range between 15 and 100 mg per day, doses above 100 mg lead to more side effects. Adverse events include paresthesia, loss of appetite, dizziness, insomnia, anxiety and difficulties finding words. Topiramate might be also effective in the treatment of chronic migraine with or without medication overuse.
引用
收藏
页码：184 / +
页数：9
相关论文
共 50 条
  • [31] Efficacy of topiramate in migraine prophylaxis: A retrospective chart analysis
    Von Seggern, RL
    Mannix, LK
    Adelman, JU
    HEADACHE, 2002, 42 (08): : 804 - 809
  • [32] Paresthesia as a favorable predictor of migraine prophylaxis using topiramate
    Lee, S.-T.
    Chu, K.
    Park, J.-E.
    Park, H.-J.
    Park, J.-H.
    Lee, S.-H.
    Kim, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (06) : 654 - 658
  • [33] Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study
    Mei, D
    Capuano, A
    Vollono, C
    Evangelista, M
    Ferraro, D
    Tonali, P
    Di Trapani, G
    NEUROLOGICAL SCIENCES, 2004, 25 (05) : 245 - 250
  • [34] Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study
    D. Mei
    A. Capuano
    C. Vollono
    M. Evangelista
    D. Ferraro
    P. Tonali
    G. Di Trapani
    Neurological Sciences, 2004, 25 : 245 - 250
  • [35] A Randomized, One-Year Clinical Trial Comparing the Efficacy of Topiramate, Flunarizine, and a Combination of Flunarizine and Topiramate in Migraine Prophylaxis
    Luo, Ning
    Di, Wei
    Zhang, Aiwu
    Wang, Ying
    Ding, Minghui
    Qi, Weiwei
    Zhu, Yingting
    Massing, Mark W.
    Fang, Yannan
    PAIN MEDICINE, 2012, 13 (01) : 80 - 86
  • [36] Topiramate-Induced Intractable Cough During Migraine Prophylaxis
    Maggioni, Ferdinando
    Mampreso, Edoardo
    Mainardi, Federico
    Lisotto, Carlo
    Malvindi, Maria Lucia
    Zanchin, Giorgio
    HEADACHE, 2010, 50 (02): : 301 - 304
  • [37] Efficacy of Topiramate Alone and Topiramate Plus Vitamin D3 in the Prophylaxis of Pediatric Migraine: A Randomized Clinical Trial
    Fallah, Razieh
    Yazd, Saeedreza Sarraf
    Sohrevardi, Seid Mojtaba
    IRANIAN JOURNAL OF CHILD NEUROLOGY, 2020, 14 (04) : 77 - 86
  • [38] Topiramate-induced myoclonus and psychosis during migraine prophylaxis
    Miller, April D.
    Prost, Valerie M.
    Bookstaver, P. Brandon
    Gaines, Kenneth J.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (14) : 1178 - 1180
  • [39] Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial
    Lai, K. -L.
    Niddam, D. M.
    Fuh, J. -L.
    Chen, S. -P.
    Wang, Y. -F.
    Chen, W. -T.
    Wu, J. -C.
    Wang, S. -J.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 135 (04): : 476 - 483
  • [40] Hypomania complicating topiramate therapy for migraine prophylaxis
    Okuyucu, E.
    Melek, I. M.
    Duman, T.
    Tunc, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (03) : E6 - E6
12345